Drug Profile
Research programme: anti-somatostatin vaccines - Braasch Biotech
Alternative Names: JH17; JH18; Somatovac®Latest Information Update: 23 Mar 2023
Price :
$50
*
At a glance
- Originator Braasch Biotech
- Class Peptide vaccines
- Mechanism of Action Immunomodulators; Somatostatin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Obesity; Somatotropin deficiency; Type 2 diabetes mellitus
Most Recent Events
- 23 Mar 2023 Discontinued - Preclinical for Obesity in USA (Parenteral)
- 23 Mar 2023 Discontinued for Somatotropin deficiency (In children) in USA (Parenteral)
- 23 Mar 2023 Discontinued for Type 2 diabetes mellitus in USA (Parenteral)